Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Evaluation of a new porous titanium hip implant

Official title: Prospective, Multicentre, Non-randomised, Open Study Evaluating the Efficacy and Fixation of the Mpact 3D Metal Monolit Cup

Run by Medacta International SA · NCT06748885 · Data updated 2026-11-12

This study is testing a new hip implant made of porous titanium to see if it helps patients recover better and move more easily after hip surgery.

More Total Hip Arthroplasty (THA) trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment88 (estimated)
SponsorMedacta International SA
Industry-sponsored
Locations3 sites (Nantes and 2 other locations)
StatusRecruiting
StartedFebruary 28, 2024
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedOctober 8, 2026
Trial IDNCT06748885 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 18 to 75 who are eligible for primary total hip arthroplasty and covered by the French Social Security system.

Probably not a fit

Patients with inflammatory arthritis, previous hip surgeries, or severe comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the Mpact 3D Metal Monolith cup, a new implant designed for total hip arthroplasty (THA). The study aims to assess the implant's performance in terms of osseointegration, joint stability, and range of motion. By utilizing a porous titanium coating, the implant promotes bone growth and provides enhanced primary stability. The study will involve patients eligible for primary THA and will gather data on their outcomes post-surgery.

Why it matters

Potential benefit: If successful, this study could lead to improved outcomes and quality of life for patients undergoing total hip arthroplasty.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving hip implant technology and outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient with a disease that corresponds to the indications for use of Medacta implants (according to the instructions for use)
2. Patient eligible for primary total hip arthroplasty
3. Patient aged between 18 and 75 years
4. Patient covered by the French Social Security system or an equivalent protection scheme.
5. Patient able, in the investigator's opinion, to comply with the requirements of the study.

Exclusion Criteria:

1. Patient suffering from inflammatory arthritis
2. Previously operated hip
3. Patient requiring a transplant
4. Hip tumour involved
5. Patient with progressive local or systemic infection
6. Severe acetabular dysplasia
7. Patient with muscle loss, neuromuscular disease or vascular impairment of the affected limb.

4\. Patient with known medical problems that may compromise independent recovery of mobility 5. Patient with a BMI greater than 40 kg/m². 6. Patient with major cognitive impairment that prevents him/her from fully understanding the requirements of the study 7. Patient living in a geographical area where study follow-up is not possible. 8. Patient taking part in interventional research 9. Minor patient 10. Protected adult patient 11. Vulnerable person according to article L1121-6 of the Public Health Code

Where it's running

  • Hôpital Cochin
    Paris, France
    Recruiting
  • Clinique Brétéché
    Nantes, France
    Not yet recruiting
  • Hôpital Lariboisière
    Paris, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.